Hologic's Cynosure division launches TempSure™ Vitalia in North America
Hologic's Cynosure division announced the North American launch of TempSure™ Vitalia, an FDA-cleared and Health Canada-approved advanced radiofrequency treatment. TempSure™ Vitalia delivers therapeutic heat to internal and external vaginal tissue to improve local circulation. July 11, 2018